Pulmonary biofilm-based chronic infections and inhaled treatment strategies.

Ding, Li; Wang, Jieliang; Cai, Shihao; Smyth, Hugh; Cui, Zhengrong

Ding, Li; Wang, Jieliang; Cai, Shihao; Smyth, Hugh; Cui, Zhengrong.

Afiliação

Ding L; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.
Wang J; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.
Cai S; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.
Smyth H; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: hugh.smyth@austin.utexas.edu.
Cui Z; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: zhengrong.cui@austin.utexas.edu.

Int J Pharm ; 604: 120768, 2021 Jul 15.

Article em En | MEDLINE | ID: mdl-34089796

Assuntos

Fibrose Cística; Infecções por Pseudomonas; Antibacterianos/uso terapêutico; Biofilmes; Fibrose Cística/tratamento farmacológico; Humanos; Pulmão; Infecções por Pseudomonas/tratamento farmacológico; Pseudomonas aeruginosa

Palavras-chave

Antimicrobial agents; Biofilm; Drug delivery; Infections; Inhalation; Inhalation devices; Liposome; Pulmonary

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Pseudomonas / Fibrose Cística Limite: Humans Idioma: En Revista: Int J Pharm Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google